適體市場:按類型（核酸、□適體）、應用、最終用戶、地區 - 規模、份額、前景、機會分析，2022-2030 年

適配體是短的單鏈 DNA 或 RNA（ssDNA 或 ssRNA）分子，可以高度特異性地結合特定的靶蛋白、脂質和核酸分子。適體也可以與藥物偶聯並充當藥物遞送系統。例如，通過將適體與化學治療劑結合，可以僅靶向並結合癌細胞，而不影響健康組織。此外，引發不需要的免疫反應的可能性低、熱穩定性高和成本效益高，預計會增加對適體的需求。適體是通過一種稱為指數富集配體系統進化 (SELEX) 的技術製造的，該技術需要時間和迭代步驟。為了克服這一缺點，醫療設備製造商 Vivonics Inc. 開發了一種稱為 RIDA（Rapid Isolation of DNA Aptamers）的一步高速技術並獲得了專利，用於分離具有高親和力和高選擇性的適體。預計這些因素將推動適體的採用。

市場動態

預計主要市場參與者的許可協議等無機策略的增加將在預測期內推動全球適體市場。例如，2022 年 9 月，生物技術公司 CAGE Bio Inc. 和研究型公司 TAGCyx Biotechnologies Inc. 宣布，他們已簽訂許可協議，開發一種免疫皮膚病藥物 TAGX-0003。根據該協議，CAGE Bio Inc.將獲得開發藥物（TAGX-0003）的許可，TAGCyx Biotechnologies Inc.將獲得預付款、銷售裡程碑和與銷售相關的特許權使用費。 TAGX-0003是一種具有強干擾素Gamma拮抗活性的DNA適配體，有望成為一種無創、有效、安全的皮膚病穿透性治療藥物。

這項研究的主要特點

• 本報告對全球適體市場進行了深入分析，提供了以 2021 年為基準年的預測期 (2022-2030) 的市場規模和復合年增長率 (CAGR%)。
• 它揭示了不同細分市場的潛在收入機會，並為該市場概述了一個有吸引力的投資建議矩陣。
• 它還提供重要的見解，例如市場驅動因素、制約因素、機會、新產品發布或批准、市場趨勢、區域前景以及主要參與者採用的競爭戰略。
• 根據公司亮點、產品組合、主要亮點、績效和戰略等參數介紹全球適體市場領先企業的概況。
• 本研究涵蓋的主要公司包括 Ophthotech Corporation、Aptamer Sciences, Inc.、Novartis AG、NeoNeuro SAS、Aptagen LLC、Aptus Biotech S.L.、AM Biotechnologies, LLC、Base Pair Biotechnologies、Vivoonics Inc.、CAGE Bio Inc ., TAGCyx Biotechnologies Inc., AstraZeneca, GlyTech, Inc., GC Biopharma Corp., Achiko AG, Agilent Technologies, Inc., SomaLogic Operating Co., Inc., Amsbio, and IVERIC bio, Inc.,
• 這份報告中的見解將使企業營銷人員和高管能夠就未來的產品發布、類型升級、市場擴張和營銷策略做出明智的決策。
• Aptamers 全球市場報告面向該行業的各種利益相關者，包括投資者、供應商、產品製造商、分銷商、新進入者和金融分析師。
• 利益相關者可以通過用於分析全球適體市場的各種戰略矩陣來促進決策制定。

內容

第 1 章目的和先決條件

• 調查目的
• 先決條件
• 縮寫說明

第二章市場展望

• 報告內容
  • 市場定義和範圍
• 執行摘要
  • 市場概況:按類型分類
  • 市場概況:按應用分類
  • 市場概況:按最終用戶分類
  • 市場概況:按地區
• 連貫機會圖 (COM)

第3章市場動態、規律及趨勢分析

• 市場動態
  • 司機
  • 約束因素
  • 市場機會
• 影響分析
• 市場趨勢
• 近期趨勢
• 收購和合作場景
• 技術概覽
• 監管情景
• 價格分析
• 害蟲分析

第 4 章全球適體市場:冠狀病毒 (COVID-19) 大流行的影響

• 總體影響
• 政府舉措
• COVID-19 對市場的影響

第 5 章全球適體市場:按類型，2017-2030

• 核酸系統
• 基於 DNA 的適體
• 基於 RNA 的適體
• XNA適體
• □適體

第 6 章全球適體市場:按應用，2017-2030

• 診斷
• 治療藥物
• 研發領域

第 7 章全球適體市場:按最終用戶分類，2017-2030

• 生物技術公司、製藥公司
• 學術和研究機構
• 委託研究機構

第 8 章全球適體市場:按地區劃分，2017-2030

• 北美
• 美國
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲地區
• 歐洲
• 英國
• 德國
• 意大利
• 法國
• 西班牙
• 俄羅斯
• 其他歐洲地區
• 亞太地區
• 中國
• 印度
• 日本
• 東盟
• 澳大利亞
• 韓國
• 其他亞太地區
• 中東
• 海灣合作委員會
• 以色列
• 其他中東地區
• 非洲
• 北非
• 中非
• 南非

第9章競爭格局

• Ophthotech Corporation
• Aptamer Sciences, Inc.
• Novartis AG
• NeoNeuro SAS
• Aptagen, LLC
• Aptus Biotech S.L.
• AM Biotechnologies, LLC
• Base Pair Biotechnologies
• Vivonics Inc.
• CAGE Bio Inc.
• TAGCyx Biotechnologies Inc.
• AstraZeneca
• GlyTech, Inc.
• GC Biopharma Corp.
• Achiko AG
• Agilent Technologies, Inc.
• SomaLogic Operating Co., Inc.
• Amsbio
• IVERIC bio, Inc.,

第 10 章

• 調查方法
• 關於出版商

Aptamers are short single-stranded DNA or RNA (ssDNA or ssRNA) molecules that bind to a specific target protein, lipid, or nucleic acid molecules with high specificity. Aptamers can also be conjugated to drugs, and work as drug-delivery systems. For example, aptamers have been conjugated with chemotherapy drugs to turn target and bind to only cancerous cells and leave healthy tissue untouched. Furthermore, factors such as lesser possibility of provoking undesired immune responses, high thermal stability, and cost-efficiency provide are expected to boost demand for aptamers. These are produced through a technique called Systematic Evolution of Ligands by Exponential enrichment (SELEX), which is time-consuming and involves iterative steps. Thus, to overcome this disadvantage, Vivonics Inc., a medical device company, developed and patented a one-step rapid technique named Rapid Isolation of DNA Aptamers (RIDA) for the isolation of high affinity and high selectivity aptamers. Such factors are expected to fuel the adoption of aptamers.

Market Dynamics

Increasing number of inorganic strategies such as license agreement by the key market players is expected to drive the global aptamers market over the forecast period. For instance, in September 2022, CAGE Bio Inc., a biotechnology company and TAGCyx Biotechnologies Inc., a research based company, announced that they had executed a license agreement for the development of TAGX-0003 for the treatment of Immuno dermatology diseases. Under this agreement, CAGE Bio Inc. will receive a license to develop the drug (TAGX-0003) and TAGCyx Biotechnologies Inc., will receive an upfront payment, sales milestone payments and sales related royalties. TAGX-0003 is a DNA aptamer that possess potent interferon gamma antagonistic activity which penetrates into the skin enabling a non-invasive, efficacious and safe treatment for dermatological diseases.

Key features of the study:

• This report provides an in-depth analysis of the global aptamers market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global aptamers market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Ophthotech Corporation, Aptamer Sciences, Inc., Novartis AG, NeoNeuro SAS, Aptagen LLC, Aptus Biotech S.L., AM Biotechnologies, LLC, Base Pair Biotechnologies, Vivonics Inc., CAGE Bio Inc., TAGCyx Biotechnologies Inc., AstraZeneca, GlyTech, Inc., GC Biopharma Corp., Achiko AG, Agilent Technologies, Inc., SomaLogic Operating Co., Inc., Amsbio, and IVERIC bio, Inc.,
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global aptamers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global aptamers market

Detailed Segmentation:

• Global Aptamers Market, By Type:
  • Nucleic Acid Aptamers
    • DNA-based Aptamers
    • RNA-based Aptamers
    • XNA-based Aptamers
  • Peptide Aptamers
• Global Aptamers Market, By Application:
  • Diagnostics
  • Therapeutics
  • Research and Development
• Global Aptamers Market, By End User:
  • Biotechnology and Pharmaceutical Companies
  • Academic and Research Institutions
  • Contract Research Organization
• Global Aptamers Market, By Region:
  • North America
    • By Country
  • U.S.
  • Canada
  • Latin America
    • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Country
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Ophthotech Corporation*
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Aptamer Sciences, Inc.
  • Novartis AG
  • NeoNeuro SAS
  • Aptagen, LLC
  • Aptus Biotech S.L.
  • AM Biotechnologies, LLC
  • Base Pair Biotechnologies
  • Vivonics Inc.
  • CAGE Bio Inc.
  • TAGCyx Biotechnologies Inc.
  • AstraZeneca
  • GlyTech, Inc.
  • GC Biopharma Corp.
  • Achiko AG
  • Agilent Technologies, Inc.
  • SomaLogic Operating Co., Inc.
  • Amsbio
  • IVERIC bio, Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Type
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• Recent Developments
• Acquisitions and Partnerships Scenario
• Technology Overview
• Regulatory Scenario
• Pricing Analysis
• PEST Analysis

4. Global Aptamers Market - Impact of Coronavirus (Covid-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the market

5. Global Aptamers Market, By Type, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Nucleic Acid
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• DNA-based Aptamers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• RNA-based Aptamers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• XNA-based Aptamers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Peptide Aptamers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Aptamers Market, By Application, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Diagnostics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Therapeutics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Research and Development
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Aptamers Market, By End User, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Biotechnology and Pharmaceutical Companies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Academic and Research Institutions
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Contract Research Organization
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Aptamers Market, By Region, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application , 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Ophthotech Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Aptamer Sciences, Inc.
• Novartis AG
• NeoNeuro SAS
• Aptagen, LLC
• Aptus Biotech S.L.
• AM Biotechnologies, LLC
• Base Pair Biotechnologies
• Vivonics Inc.
• CAGE Bio Inc.
• TAGCyx Biotechnologies Inc.
• AstraZeneca
• GlyTech, Inc.
• GC Biopharma Corp.
• Achiko AG
• Agilent Technologies, Inc.
• SomaLogic Operating Co., Inc.
• Amsbio
• IVERIC bio, Inc.,

10. Section

• Research Methodology
• About Us